A single-blind, randomized, placebo-controlled phase II study to evaluate the impact of oral bisphosphonate treatment on bone mineral density in osteopenic women receiving adjuvant aromatase inhibitors: Interim analysis of “BONADIUV” trial.
Vieri Scotti
No relevant relationships to disclose
Icro Meattini
No relevant relationships to disclose
Sara Cecchini
No relevant relationships to disclose
Maria Laura De Feo
No relevant relationships to disclose
Calogero Saieva
No relevant relationships to disclose
Carla De Luca Cardillo
No relevant relationships to disclose
Lorenzo Livi
No relevant relationships to disclose